Revealing underlying regulatory mechanisms of LINC00313 in Osimertinib-resistant LUAD cells by ceRNA network analysis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Revealing underlying regulatory mechanisms of LINC00313 in Osimertinib-resistant LUAD cells by ceRNA network analysis

Published:2024-05 Issue: Volume:43 Page:101895
ISSN:1936-5233
Container-title:Translational Oncology
language:en
Short-container-title:Translational Oncology

Author:

Ding Dandan,Xu Chenguang,Zhang Jufeng,Zhang Ying,Xue Lipeng,Song Jingjing,Luo Zhiming,Hong Xiaoyu,Wang Jian,Liang Weicheng,Xue Xingyang

Funder

Wu Jieping Medical Foundation

National Natural Science Foundation of China

Science and Technology Planning Project of Guangdong Province

National Natural Science Foundation of China-Guangdong Joint Fund

Publisher

Elsevier BV

Reference34 articles.

1. Osimertinib in untreated EGFR-mutated advanced non-small-cell lung cancer;Soria;N. Engl. J. Med.,2018

2. Non-small cell lung cancer, version 3.2022, NCCN clinical practice guidelines in oncology;Ettinger;J. Natl. Compr. Canc. Netw.,2022

3. The evolving landscape of resistance to osimertinib;Schoenfeld;J. Thorac. Oncol.,2020

4. Mechanisms of osimertinib resistance and emerging treatment options;Schmid;Lung. Cancer,2020

5. MET alterations in NSCLC-Current Perspectives and Future Challenges;Remon;J. Thorac. Oncol.,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apoptosis and Inflammation Involved with Fluoride-Induced Bone Injuries;Nutrients;2024-07-31

2. Predictive and Mechanistic Analysis of Dynamic 5-Node ceRNA Regulatory Network in Lung Adenocarcinoma;Hans Journal of Biomedicine;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP